UK AI in Healthcare Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets

The UK AI in Healthcare Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global UK AI in Healthcare market. This report explores all the key factors affecting the growth of the global UK AI in Healthcare market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141690/

Report Overview

The European AI in Healthcare market size was valued at USD 2.04 billion in 2020 and is forecasted to reach the market size of USD 50.42 billion by 2028, expanding at a compound annual growth rate (CAGR) of 49.3% during the forecast period.

Artificial Intelligence has made life easier in all aspects. Healthcare is not an exception. Advances in medicine, supported by progress in public health, research, innovation and technology have significantly reduced morbidity and mortality. The healthcare sector is developing rapidly by making use of Artificial Intelligence to increase productivity while reducing the huge burden on healthcare workers.

AI has various applications in healthcare. It enables medical practitioners to retrieve information, interpret images acquired during scans and make treatment plans for the medical procedures. In addition to the clinical aspect, Artificial Intelligence is also proving beneficial in research activities. Globally, government and private organizations are initiating the incorporation of Artificial Intelligence in their research endeavours to accelerate developments surrounding COVID-19 vaccines.

AI has gained significant traction during the pandemic from combining scientific papers on coronaviruses to searching CT scans for COVID-19 symptoms. The White House partnered with AI research institutions to mine scientific literature to better understand the disease. Even amid economic uncertainties due to COVID-19, Healthcare AI companies have gained numerous opportunities to thrive upon owing to the reason that they minimize human interaction, thus minimising the risk of transmission and shielding the frontline workers.

The UK is recognized for having advanced healthcare infrastructure. The NHS has been adopting various changes to enhance its services and offer patient control over their healthcare. Addenbrooke hospital in Cambridge is using Microsofts InnerEye system to automatically process scans for patients with prostate cancer. HeartFlows AI technology is also being used in the NHS to analyse CT scans of patients who are suspected coronary heart to have CHD and creates a personalised 3D model of the heart that shows the blood flow.

With further implementation of AI in healthcare, it is believed that health inequalities can be reduced where access to care is dramatically improved and quality and standards of care are continuously driven up as machines learn more about the conditions of the people they are treating. This offers numerous opportunities that opens the market for newer technological innovations in the field of healthcare in the UK.

Market Drivers

The market is majorly fuelled by growing government initiatives and their collaboration to promote implementation of AI in Healthcare. In addition to this, there is a rise in need to reduce healthcare costs at the same time, increase computing power by minimising hardware costs.

The market is driven by the increasing influx of large and complex healthcare datasets which can be simplified and analysed with Artificial Intelligence.

There is an imbalance between the healthcare workforce and the patients. Artificial Intelligence restores this balance, further fuelling the market growth. Increase in use of precision medicines and clinical trial processes demands the deployment of Artificial Intelligence which further propels the market. Increased funding for Research and Development in the field contributes to the growth of the market. It is also driven by the ongoing COVID-19 pandemic in the country.

Type of Artificial Intelligence in Healthcare

The AI technologies that play an important role in healthcare are as follows:

Machine learning neural networks and deep learning
Natural language processing
Rule-based expert systems
Physical robots
Robotic process automation

The most common form of AI is Machine Learning which is a statistical technique for fitting models to data and to learn by training models with data.
To Know More About COVID-19 Impact On UK AI in Healthcare Market @ https://www.prudentmarkets.com/sample-request/141690/

Market Segmentation

By Product:

UK AI in Healthcare market is segmented into AI integrated Hardware, Software and Services.

AI integrated Hardware includes Processor, Memory and Network.

Software includes on-premises and cloud solutions along with an AI platform which houses the machine learning framework and the Application Program Interface.

Services include Deployment and Integration of AI hardware and software solutions, Support and Maintenance.

By technology:

Based on the technology used, the United Kingdom AI in Healthcare market is segmented into Machine Learning, Natural Language Processing, Context Aware Computing and Computer Vision.

Machine Learning has further types like Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning and others. Imaging and diagnostics, and drug discovery are among the applications that use deep learning. It is also used to automate data analysis to deal with large volumes of data.

Natural Language Processing is widely used by clinical and research community in healthcare to develop and manage semi-structured and unstructured textual documents, such as electronics health reports, pathology reports, and clinical notes. The demand has risen with increase in number of healthcare institutions structuring and interpreting their data more accurately.

Context Aware Computing has seen a boom after the development of sophisticated hard and soft sensors.

Computer Vision has been responsible for significant contributions to the fields of surgery and therapy. This offers precise diagnoses, minimising false positives. Computer vision algorithms are trained to utilise huge amounts of data to detect the presence of a condition which the human doctors might miss owing to their sensory limitations.

By End-Use Application:

Based on the end use application, the market is segmented into patient data and risk analysis, Inpatient care and hospital management, medical imaging and diagnostics, Lifestyle management and remote patient monitoring, Virtual Assistants, Drug discovery, Research, Healthcare Assistance Robots, Precision medicine, Emergency room and surgery, Wearables, Mental Health and Cybersecurity.

Patient risk algorithms consider several variables and express the results as the percentage risk of developing a major fatal or nonfatal disease in the coming years. They offer solutions that can provide predictive insights into patient health using machine learning and natural language processing algorithms.

AI and machine-learning methods have the potential to improve the quality and lower the cost of patient care through Clinical Decision Support Systems.

Healthcare AI start-ups work in the field of Imaging and Diagnostics generating a large volume of challenging data which is simplified with extraction of insights using machine learning.

The Bolton NHS Foundation Trust partnered with Qure.ai, an Indian healthcare AI start-up for monitoring COVID-19 patients that has developed qXR solution which is a diagnostic software used to detect the findings that are indicative of COVID-19 and also helps in the quantifying the volume of the infection.

Ibex Medical Analytics has pioneered the use of AI in pathology as a means of improving diagnosis of prostate cancer. Ibex's GalenTM Prostate solution will be used in 6 NHS hospitals in the UK.

Kheiron Medical has been working to increase adoption of deep learning software, which aims to solve critical challenges in the NHS Breast Screening Programme by reducing missed cancers, tackling the escalating shortage of radiologists and improving delays.

By End User:

Based on the end user, the UK AI in Healthcare market is segmented into the following:

Hospitals and healthcare providers, where AI is used to predict and prevent readmissions and improve operations of hospitals

Patients, where smartphone applications and wearables are targeted to promote the adoption of AI.

Pharmaceuticals and Biotechnological companies, where drug discovery, precision medicine and research are targeted to drive the use of AI.

Healthcare Payers, where AI is promoted for use in managing risks, identifying claims, trends and for maximising payment accuracy.

Others that include patient data, risk analysis etc.

Top 5 Major Players

IBM Corporation, NVIDIA Corporation, Nuance Communications, Microsoft and Intel Corporation are the major players in the UK AI market.

At AMIA 2020, IBM showcased its work related to AI in Healthcare through injection of clinical knowledge and by incorporating an adaptive healthcare system. One such example is Watson for Drug Discovery from IBM Watson Health is a platform that mines text and data in medical literature to identify, assess, and rigorously formalize the relationships among genes, diseases, and drugs to help researchers uncover potential new therapies and find new uses for existing medicines.

NVIDIA develops GPUs and delivers value to its consumers through PC, mobile, and cloud architecture. NVIDIA's partnership with GSK's AI powered lab for the discovery of new medicines and vaccines is done on the basis of its expertise in GPU optimization and high-performance computational pipeline development along with its significant contributions to the field through NVIDIA Clara Discovery, NVIDIA DGX A100 systems and so on.

Nuance Communications and Microsoft are focused on transforming patient care with AI powered solutions for physicians, radiologists and hospitals. Microsoft is a global leader offering intelligent tools and solutions that empower clinical and operational efficiency and save costs. Azure Synapse Analytics, Azure Health GitHub Repo, Microsoft Healthcare bot, Azure API for FHIR, Azure AI and ML and Azure IoT for Healthcare are scalable platforms that bring conversational AI to healthcare.

Intel Corporation has contributed its significant share to the field of AI by transforming frontline medical care and improving patient experience for a few of their clients. Intel's technology innovations are enabling the healthcare sector with data-driven insights and artificial intelligence by introducing various tools and solutions to simplify AI deployment in healthcare.

Healthcare Policies and Regulatory Landscape

Recent times have witnessed numerous advancements in the field of healthcare dedicating their successes to Artificial Intelligence. In the last ten years, there has been requirements and guidance for software manufacturers to demonstrate compliance to medical device regulations and to place their products on the market.

The UK Government aims to create an international approach to AI for healthcare. In March 2019, the UK Government launched Evidence Standards Framework for Digital Health Technologies. The UK Government established NHSX as a new body responsible for setting policy and best practice around the use of digital technologies in healthcare in England. NHSX created the NHS AI Lab to bring together government, health and care providers, academics and technology companies to help address healthcare challenges.

The 2019 NHS Long Term Plan identifies the improved use of AI in the healthcare system as a priority which has been actively pursued by the Government. To further its support, In September 2020, NHSX, the organisation driving the digital transformation of health and social care, announced that 42 tech companies will receive a share of over £50M ($66M) in phase one of its £140M ($186M) AI in Health and Care Award.

The ICO is developing an AI auditing framework to improve guidance and support to the AI sector so that healthcare organisations like NHS Trusts can implement data-driven technology solutions safely and legally.

NHSX has launched the AI in Health and Care Survey 2021, in order to gain new perspectives on the progress of AI in the healthcare aspect till date.

Following Brexit, the UK Government has indicated a departure from the EU medical devices rules and has announced that it will not implement the Medical Devices Regulation (EU) 2017/745 into national law when it took effect on 26 May 2021. The UK has instead introduced a new national regime that involves the application of a "UKCA mark" to devices placed on the market in Great Britain which includes England, Scotland and Wales.

Highlighted Segments of UK AI in Healthcare Market:

Industry Overview: The first section of the research study covers an overview of the global UK AI in Healthcare Market, market status and prospects, and product range. In addition, it provides highlights of the major segments of the global Market, i.e., region, type, and application segments.

Competitive Analysis: This report illuminates important mergers and acquisitions, business expansion, product or service differences, market concentration, the competitive status of the global UK AI in Healthcare Market, and market size by player.

Company Profiles and Key Data: This section covers companies profiling the major players in the global UK AI in Healthcare Market based on the aforementioned revenue, products, business, and other factors.

Market size by type and application: In addition to providing an in-depth analysis of the industry size by type and application, this section provides research on top end users or consumers and potential applications.

Market Dynamics: This report covers the drivers, trends, and opportunities of the global UK AI in Healthcare Market. This section also includes Porter's analysis of five forces.

Findings and Conclusions: It provides strong recommendations for new as well as established players for securing a position of strength in the global UK AI in Healthcare Market.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141690/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global UK AI in Healthcare Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global UK AI in Healthcare Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the UK AI in Healthcare market
Chapter 2: Exclusive Summary - the basic information of the UK AI in Healthcare Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the UK AI in Healthcare
Chapter 4: Presenting the UK AI in Healthcare Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the UK AI in Healthcare market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Why should you purchase this report?

-Prudent Markets provides the vital historical and analysis data of global UK AI in Healthcare market.
-The report provides the entire assessment of the future market and altering market scenario or behavior.
-All the business decision could be backed through the several strategic business methodologies offered in the report.
-An extra edge in the competitive market could be obtained from this elaborative research report
-The report offers all the competitive landscape, growth drivers, applications, market dynamics, and other necessary details as well.

Purchase this report (Single User License) @ https://www.prudentmarkets.com/checkout/?id=141690&license_type=su

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the UK AI in Healthcare Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.